C. John

发表

Specific in vivo binding of [125I]-iodomelatonin to melatonin receptors in rat brain

B. Zeeberg, R. Reba, M. Gitler, 1990, Neuropharmacology.

Labelled sigma receptor ligands: can their role in neurology and oncology be extended?

A. Bossuyt, V. Caveliers, T. Lahoutte, 2001, European Journal of Nuclear Medicine.

Targeting sigma receptor-binding benzamides as in vivo diagnostic and therapeutic agents for human prostate tumors.

W. Bowen, T. Moody, C. John, 1999, Cancer research.

Synthesis, in vitro binding, and tissue distribution of radioiodinated 2-[125I]N-(N-benzylpiperidin-4-yl)-2-iodo benzamide, 2-[125I]BP: a potential sigma receptor marker for human prostate tumors.

M. E. Gulden, W. Bowen, M. Thakur, 1998, Nuclear medicine and biology.

Synthesis and evaluation of [18F] labeled benzamides: high affinity sigma receptor ligands for PET imaging.

W. Bowen, C. Dence, M. Welch, 1997, Nuclear medicine and biology.

Synthesis, in vitro validation and in vivo pharmacokinetics of [125I]N-[2-(4-iodophenyl)ethyl]-N-methyl-2-(1-piperidinyl) ethylamine: a high-affinity ligand for imaging sigma receptor positive tumors.

M. E. Gulden, W. Bowen, C. John, 1996, Nuclear medicine and biology.

Effects of Production of Abnormal Proteins on the Rate of Killing of Escherichia coli by Streptomycin

C. John, Mary A. WYKAt, 2003 .

Sigma receptors are expressed in human non-small cell lung carcinoma.

W. Bowen, T. Moody, C. John, 1995, Life sciences.

Sigma ligands inhibit the growth of small cell lung cancer cells.

T. Moody, C. John, J. Leyton, 2000, Life sciences.

(Arg15, Arg21) VIP: Evaluation of Biological Activity and Localization to Breast Cancer Tumors

T. Moody, W. Eckelman, C. John, 1998, Peptides.

Synthesis and Pharmacological Characterization of 4-[125I]-N-(N-Benzylpiperidin-4-yl)-4-iodobenzamide: A High Affinity σ Receptor Ligand for Potential Imaging of Breast Cancer

M. E. Gulden, W. Bowen, T. Moody, 1995 .

Synthesis and characterization of [125I]-N-(N-benzylpiperidin-4-yl)-4- iodobenzamide, a new sigma receptor radiopharmaceutical: high-affinity binding to MCF-7 breast tumor cells.

W. Bowen, C. John, B. J. Vilner, 1994, Journal of medicinal chemistry.

Increased binding to sigma sites of N-[1'(2-piperidinyl)ethyl)-4-[I-125]-iodobenzamide (I-125-PAB) with onset of tumor cell proliferation.

T. Moody, C. John, P. Zamora, 1998, Life sciences.

Labeling of proteins using [105Rh]Rh-4-(p-aminobenzyl)-diethylenetriamine.

C. John, J. Lo, M. Pillai, 1990, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

.mu.-Oxo-bis(oxo) dinuclear complexes of technetium(V) with amine phenol ligands: syntheses, characterization, and x-ray crystal structures

C. John, J. Lo, M. Pillai, 1990 .

Chelation of iron within the erythrocytic Plasmodium falciparum parasite by iron chelators.

V. Hu, V. Gordeuk, C. John, 1999, Molecular and biochemical parasitology.

Palladium(II) complexes of N2O2 and N2S2 ligands: Syntheses and X-ray crystal structures

C. Barnes, C. John, M. Pillai, 1993 .

Technetium complexes of pentadentate amine-phenol ligands

R. A. Holmes, C. John, W. Volkert, 1993 .

Synthesis and characterization of a cationic tin(IV) complex : relevance to nuclear medicine

C. Costello, C. John, E. O. Schlemper, 1992 .

Synthesis and characterization of neutral oxotechnetium(V) bisaminoethanethiol complexes : potential brain imaging agents

H. Kung, S. Wehrli, P. Carroll, 1992 .

A malignant melanoma imaging agent: synthesis, characterization, in vitro binding and biodistribution of iodine-125-(2-piperidinylaminoethyl)4-iodobenzamide.

W. Bowen, R. Reba, T. Saga, 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Labeling of human IgG with rhodium-105 using a new pentadentate bifunctional ligand.

C. John, M. Pillai, D. E. Troutner, 1990, Bioconjugate chemistry.

Tricyclic heterocycles with bifunctional silicon centers

C. John, L. Chang, Joyce C. Corey, 1986 .

Aminothiol multidentate chelators as antimalarials.

V. Gordeuk, C. John, M. Loyevsky, 1997, Biochemical pharmacology.

Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines.

W. Bowen, C. John, B. J. Vilner, 1995, Cancer research.

An improved synthesis of [125I]N-(diethylaminoethyl)-4-iodobenzamide: a potential ligand for imaging malignant melanoma.

R. Reba, T. Saga, S. Kinuya, 1993, Nuclear medicine and biology.

Synthesis, characterization and biodistribution of a new hexadentate aminethiol ligand labeled with Tc-99m.

R. Reba, C. John, C. Paik, 1992, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Preparation, radiolabeling and biodistribution of a new class of bisaminothiol (BAT) ligands as possible imaging agents.

H. Kung, M. Kung, C. John, 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Biolocalization and cell labeling properties of neutral-lipophilic 99mTc-amine-phenol chelates.

R. A. Holmes, C. John, W. Volkert, 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Labeling of human serum albumin with 105Rh-cysteine complexes.

C. John, J. Lo, M. Pillai, 1990, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

Labeling of proteins with 105Rh

C. John, J. Lo, M. Pillai, 1989 .

Synthesis, in vitro pharmacologic characterization, and preclinical evaluation of N-[2-(1'-piperidinyl)ethyl]-3-[125I]iodo-4-methoxybenzamide (P[125I]MBA) for imaging breast cancer.

R. Wahl, W. Bowen, S. Fisher, 1999, Nuclear medicine and biology.

Radiochemical purity evaluation of rhodium-105 complexes by magnesium oxide

C. John, J. Lo, M. Pillai, 1990 .

N,N'-ethylene-di-L-cysteine (EC) complexes of Ga(III) and In(III): molecular modeling, thermodynamic stability and in vivo studies.

M. Welch, R. Hancock, A. Martell, 1995, Nuclear medicine and biology.

Sigma receptor scintigraphy with N-[2-(1'-piperidinyl)ethyl]-3-(123)I-iodo-4-methoxybenzamide of patients with suspected primary breast cancer: first clinical results.

A. Bossuyt, V. Caveliers, T. Lahoutte, 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

99mTc-labeled sigma-receptor-binding complex: synthesis, characterization, and specific binding to human ductal breast carcinoma (T47D) cells.

W. Bowen, C. John, B. J. Vilner, 1997, Bioconjugate chemistry.

Radiochemical studies of technetium complexes of tetradentate amine-phenols

C. John, J. Lo, M. Pillai, 1990 .

Preparation and preliminary evaluation of 4-[211At]astato-N-piperidinoethyl benzamide.

P. Garg, M. Zalutsky, C. John, 1995, Nuclear medicine and biology.

Antineoplastic agents. 515. Synthesis of human cancer cell growth inhibitors derived from 3,4-methylenedioxy-5,4'-dimethoxy-3'-amino-Z-stilbene.

R. Pettit, C. John, E. Hamel, 2005, Journal of natural products.